China Pharma Holdings, Inc.
CPHI
$0.82
-$0.02-2.38%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -7.56% | -13.45% | 8.11% | -31.27% | 10.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.56% | -13.45% | 8.11% | -31.27% | 10.91% |
| Cost of Revenue | -22.29% | -45.14% | -16.95% | -49.63% | -42.65% |
| Gross Profit | 196.09% | 309.77% | 193.90% | 88.51% | 91.43% |
| SG&A Expenses | 174.95% | 122.43% | 12.18% | 10.50% | 156.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.85% | 10.87% | 4.11% | -36.68% | -34.07% |
| Operating Income | -185.56% | -47.28% | -0.31% | 42.16% | 63.97% |
| Income Before Tax | -175.95% | -45.51% | 0.19% | 41.72% | 63.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -175.95% | -45.51% | 0.19% | 41.72% | 63.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -175.95% | -45.51% | 0.19% | 41.72% | 63.26% |
| EBIT | -185.56% | -47.28% | -0.31% | 42.16% | 63.97% |
| EBITDA | -82.72% | 68.16% | 6.11% | 30.03% | 72.31% |
| EPS Basic | 78.02% | 81.44% | 65.93% | 73.96% | 81.63% |
| Normalized Basic EPS | 78.03% | 81.46% | 65.93% | 73.97% | 81.63% |
| EPS Diluted | 78.02% | 81.44% | 65.93% | 73.96% | 81.63% |
| Normalized Diluted EPS | 78.03% | 81.46% | 65.93% | 73.97% | 81.63% |
| Average Basic Shares Outstanding | 1,156.03% | 684.88% | 193.02% | 123.85% | 100.09% |
| Average Diluted Shares Outstanding | 1,156.03% | 684.88% | 193.02% | 123.85% | 100.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |